Status:
COMPLETED
Post COVID-19 Neurologic Symptoms : a Somatic Spectrum Disorder ? (SOMATiC)
Lead Sponsor:
Centre Hospitalier de Saint-Denis
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
A growing number of studies highlight the persistence of symptoms after the acute phase of SARS-CoV-2 infection, including in outpatients with mild to moderate forms of the disease. More than 80% of p...
Detailed Description
A growing number of studies highlight the persistence of symptoms after the acute phase of SARS-CoV-2 infection, including in outpatients with mild to moderate forms of the disease. More than 80% of p...
Eligibility Criteria
Inclusion
- adults (18 years-old or older)
- having had a mild or moderate COVID-19 managed on an outpatient basis during the acute phase of the infection
- COVID-19 virologically confirmed or suspected on the basis of suggestive symptoms
- spontaneously consulting for post-COVID-19 symptoms and referred for neurological advice in our center
- with neurological clinical evaluation concluding that there is no differential diagnosis.
Exclusion
- patients who were hospitalized during the acute phase of the infection
- suspected de novo neurological pathology unrelated to COVID-19
- patient refusal to participate.
Key Trial Info
Start Date :
April 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04889313
Start Date
April 22 2021
End Date
October 30 2021
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de Saint-Denis
Saint-Denis, Île-de-France Region, France, 93200